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cDNAs for rat transthyretin mRNA were cloned from a brain cDNA library. Sequencing analyses howed the presence of an additional 5’ sequence 
that had not been reported for the liver mRNA corresponding to the flanking promoter region of the gene. This additional sequence was expressed 
only in the brain, suggesting the presence of a brain-specific promoter. 
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1. INTRODUCTION 
Transthyretin (prealbumin) binds thyroid hormones 
and also binds vitamin A via the retinol binding pro- 
tein, playing an important role in their transport pro- 
cesses [l]. In addition to its well-characterized three- 
dimensional structure, both cDNA and the genome 
structures for transthyretin of several species have been 
studied [2-71. The molecular and genetic basis for ac- 
cumulation of a variant transthyretin in a heredofami- 
lial amyloidotic polyneuropathy has also been studied 
tW1. 
synthesized from the total poly(A) RNA isolated from adult rat 
hepatocytes. Hepatocytes were isolated by in situ perfusion of the 
liver with collagenase [12], and isolation of poly(A) RNA and syn- 
thesis of cDNA were done by the standard methods described [13]. 
Phages which gave strong signals were randomly selected and their 
DNAs were purified. The cDNA inserts were subcloned into pUCl8. 
Sequence analyses were done by the dideoxy chain termination 
method using the denatured plasmid DNAs as templates. Trans- 
thyretin cDNA clones were identified by computer-assisted 
alignments of the sequences with the published data [7] using the 
DNASIS program of Hitachi Software Engineering (Yokohama, 
Japan). 
In rodents, transthyretin mRNA was detected in the 
liver and in extremely high levels in the choroid plexus 
of the brain [lo]. The mRNA was described as being ex- 
pressed from the same starting site of the same gene in 
both tissues [5,11]. Multiple nuclear factors and the 
proximal regulatory regions of the mouse gene func- 
tioning in liver-specific expression have been reported 
[ll]. However, the mechanism by which the choroid 
plexus expresses this gene but not other liver-specific 
genes has not been characterized at all. 
Slot blot hybridization using the total extracts from various tissues 
of rat was carried out according to [14] and the DNA concentrations 
of the samples for normalization were determined as in [15]. The 
hybridization probes were prepared by nick translation of the 
plasmid DNAs by a standard method [13]. Plasmid DNA for probe 
A in fig.1 was constructed by ligation of a Sau3A fragment (nu- 
cleotide 11-76) of clone Bl DNA into BamHI site of pUCl8, fol- 
lowed by sequencing analysis for confirmation. 
Restriction enzymes, DNA polymerase I, T4 DNA ligase, universal 
and reverse sequence primers were obtained from Takara Shuzo 
(Kyoto, Japan). Reverse transcriptase was from Seikagaku-kogyo 
(Tokyo, Japan). [a-“P]dCTP (>700 Ci/mmol) was from ICN (CA, 
USA). 
To begin the study of brain-specific expression of 
transthyretin mRNA, we re-examined whether the 
mRNA is indeed transcribed from the same starting site 
in both the liver and the brain by cloning rat trans- 
thyretin cDNAs from a brain cDNA library. 
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2. MATERIALS AND METHODS I 1 
A brain cDNA library (Clonetech, CA, USA) was screened under 
high-stringency hybridization conditions with the “‘P-labeled cDNA 
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B 
-100 -90 -80 -70 -60 %O -40 
GACTAAGTCAATAATCAGAATCAGCAGGTTTGGAGTCAGATTGGCAGGGATCAGCAGGCTGCCTTGGGA 
L 
-30 -20 -10 
GGAGGGGGTATATAAGCCCCTTCACCAGGAGAAGTCAT~~TAGAGAT~~GCTGGCTC~~GACAG 
Fig.2. Comparison of the 5’-noncoding sequence of the brain transthyretin cDNA (Bl) with the published 5’ flanking region of the gene [7]. 
L represents the major RNA starting site (number 1) in the liver; B represents the 5’-end of clone Bl. Putative TATA boxes are underlined. 
3. RESULTS 
Four out of 8 randomly selected clones were iden- 
tified as transthyretin cDNA clones by sequencing 
analyses. Such a high proportion of transthyretin 
clones would reflect unusual cell-specific and abundant 
expression of the mRNA [lo]. Among other clones, 
two contained the sequences for mitochondrial cyto- 
chrome c oxidase for unknown reasons and two con- 
tained the sequences with no significant homologies to 
Fig.3. Slot blot analyses of albumin (I), aPoE (II), transthyretin (probe B) (Ill), and transthyretin (probe A) (IV) mRNA in various tissues. Total 
extracts were normalized by DNA contents and columns l-3 show extracts containing 0.4, 0.2 and 0.1 yg of DNA. Columns a-g show extracts 
from brain, heart, thymus, spleen, liver, kidney and lung, respectively. 
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any known sequences in the data base (GenBank R55.0 
and EMBL R15.0). 
The sequences of 4 transthyretin cDNA clones from 
the brain library were dete~ned and compared with 
the published rat sequence [7] (fig,l). Though the 
5 ‘-end of the published sequence was determined by 
primer extension analysis, clone Bl has an additional 
61 bp at the 5’-end. The 5’-noncoding sequence of the 
brain transthyretin cDNA (Bl) was then compared with 
the published 5 ‘-flanking region of the gene f7] and is 
shown in fig.2 The additional sequence of clone Bl 
matched perfectly with the flanking region including a 
TATA-like sequence. 
To examine the possibilities that the 5 ’ additional se- 
quence of BI clone is expressed in both the brain and 
the liver, or that the sequence is produced by a cloning 
artifact, total RNA from the brain and the liver was 
analyzed by dot hybridization using specific cDNA pro- 
bes. As shown in fig.3, under conditions where apoE 
[I6] and albumin 1171 mRNAs were detected as ex- 
pected, the transth~etin mRNA sequence was detected 
in both the liver and the brain when the sequence of 
clone 87 (probe B in fig.1) was used as a probe, but it 
was detected only in the brain when the additional 5 ’ 
sequence of clone Bi (probe A in fig. 1) was used. These 
results show that the 5 ’ additional sequence of B 1 clone 
is not an artifact and is expressed in the brain at a 
significant ievel but little or not at all in the liver. 
4. DISCUSSION 
Transth~etin mRNA has been reported to be ex- 
pressed in both the liver and the brain from the same 
RNA start site in both tissues f5,11]. The RNA start 
sites in the liver of mouse [5], rat [7]x and human [6] 
were reported at homologous positions, but no direct 
data have been reported on the start sites in the brain, 
Our present data show that the brain has an addi- 
tional transcriptional start site for the mRNA. This site 
is located at least 65 bp upstream of the published one 
passing over a TATA-like sequence and it is used 
significantly in the brain but little in the liver. Another 
TATA-like sequence, 5 ’ -AATAAT-3 ’ was found in 
the upstream region. Though our present results do not 
exclude the possibility that the brain uses both RNA 
start sites and quantitative studies to determine which 
is the major one in the brain are obviously necessary, 
the choroid plexus may have its specific promoter 
distinct from the liver promoter. As the liver, the 
choroid plexus should transcribe the gene efficientfy us- 
ing several activator proteins and the regulatory regions 
of the gene. The simplest mechanism would be ac- 
complished by two distinct sets of transcriptional fac- 
tors: one set for the liver and another for the choroid 
plexus. This type of regulation was shown ~amyfase in 
the liver and in the salivary gland accompanied by alter- 
native splicing [ 181. The possibility that alternative pro- 
moters are used in a tissue-specific manner without 
aiternative splicing deserves further investigation. 
Acknowledgements: We are grateful to Mr S. Hasbimoto for isola- 
tion of rat hepatocytes and to Miss N. Harada for her technical 
assistance in slot blot analyses. Thanks are also due to Dr C. Heinz- 
man (UCLA, USA) for his generous gift of mouse apoE clone. 
REFERENCES 
Ill 
w 
131 
I41 
181 
I91 
WI 
BIl 
WI 
I131 
Dickson, P.W., Aldred, A.R., Menting, G.T., Marley, P.D., 
Sawyer, W.H. and Schreiber, 0. (1987) J. Biol. Chem. 262, 
13907-13915. 
Mita, S., Maeda, S., Shimada, K. and Araki, S. (1984) Bio- 
them. Biophys. Res. Commun. I24, 558-564, 
Wakasugi, S., Maeda, S., Shimada, K., Nakasbima, H. and 
Migita, S. (1985) J. Biochem. 98, 1707-1714. 
Sundelin, J., Melhus, H., Das, S., Lind, I?., Tragsrdh, L., 
Peterson, P.A. and Rask, L, (1985) J. Biol. Chem. 260, 
6481-6487. 
Wakasugi, S., Maeda, S. and Shimada, K. (1986) J. Biochem. 
tOO, 49-58. 
Tsuzuki, T., Mita, S., Maeda, S., Araki, S. and Shimada, K. 
(1985) J. Biol. Chem. 260, 12224-12227. 
Fung, W.P., Thoma, T., Dickson, P.W-, Aldred, A.R., 
Milland, J.. Dziadek, M., Power, B., Hudson, P. and 
Schreiber, G. (1988) J. Bid. Chem. 263, 480-488. 
Dwuiet, FE. and Benson, M.D. 11984) Proc. NatL Acad. Sci, 
USA 81, 694-698. 
YamanIura, K., Wakasupi, S., Maeda, S., Inomoto, T., 
Iwanaga, T., Araki, K., Miyazaki, J. and Shimada, K. (1987) 
Dev. Genet. 8, 195-205. 
Dickson, P.W., Aldred, A.R., Marley, PD., Guo-Fen, T., 
Howlett, G.J. and Schreiber, G. (1985) Biochem, Biophys. Res. 
Commun. 127, 890-895. 
Costa, R.H., Gray~on~ D.R. and DarneR, J.E. (1989) Moi. 
Ceil. Biol. 9, 1415-1425. 
Seglen, P.G. (1976) Methods Cell Biol. 13, 29-83. 
Maniatis, T., Fritsch, E.F. and Sambrook, J. (1982) Molecular 
Cloning: A Laboratory Manual, Cold Spring Harbor 
Laboratory, Cold Spring Harbor, NY. 
Grimes, A., McArdle, H.J. and Mercer, J.F.B. (1988) Anal, 
Biochem. X72,436-443. 
Labarca, C. and Paigen, K. (1980) Anaf. Biochem. 102, 
344-352. 
Elshourbagy, N.A., Liao, W.S., Mahley, R.W. and Taylor, 
J.M. (1985) Proc. Natl. Acad. Sci. USA 82, 203-207. 
Tighman, SM. and Belayew, A. (1982) Proc. Nati. Acad. Sci. 
USA 79, 5254-5257. 
Schibler, U. and Sierra, F. (1987) Annu. Rev. Gene& 21, 
237-257, 
105 
